BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36003772)

  • 21. Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients.
    Zheng L; Zou K; Yang C; Chen F; Guo T; Xiong B
    Clin Transl Oncol; 2017 Sep; 19(9):1125-1132. PubMed ID: 28315180
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In Early Breast Cancer, the Ratios of Neutrophils, Platelets and Monocytes to Lymphocytes Significantly Correlate with the Presence of Subsets of Circulating Tumor Cells but Not with Disseminated Tumor Cells.
    Kasimir-Bauer S; Karaaslan E; Hars O; Hoffmann O; Kimmig R
    Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic and predictive role of the neutrophil-to-lymphocyte ratio and the monocyte-to-lymphocyte ratio in early breast cancer, especially in the HER2+ subtype.
    Tiainen S; Rilla K; Hämäläinen K; Oikari S; Auvinen P
    Breast Cancer Res Treat; 2021 Jan; 185(1):63-72. PubMed ID: 32948994
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival.
    Cummings M; Merone L; Keeble C; Burland L; Grzelinski M; Sutton K; Begum N; Thacoor A; Green B; Sarveswaran J; Hutson R; Orsi NM
    Br J Cancer; 2015 Jul; 113(2):311-20. PubMed ID: 26079303
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A High Monocyte-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Advanced Gallbladder Cancer Receiving Chemotherapy.
    Choi YH; Lee JW; Lee SH; Choi JH; Kang J; Lee BS; Paik WH; Ryu JK; Kim YT
    Cancer Epidemiol Biomarkers Prev; 2019 Jun; 28(6):1045-1051. PubMed ID: 30842131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Combination of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio with Liquid Biopsy Biomarkers Improves Prognosis Prediction in Metastatic Pancreatic Cancer.
    Toledano-Fonseca M; Cano MT; Inga E; Gómez-España A; Guil-Luna S; García-Ortiz MV; Mena-Osuna R; De la Haba-Rodriguez JR; Rodríguez-Ariza A; Aranda E
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33802006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlation of Prognostic Markers {CEA, Ca19.9, Neutrophil To Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)} With Progression Free Survival (PFS) in Advanced/Metastatic Gallbladder Carcinoma.
    Naik MD; Kataria SP; Kumar G; Singh R
    J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio and decreased platelet-to-lymphocyte ratio are associated with poor prognosis in multiple myeloma.
    Shi L; Qin X; Wang H; Xia Y; Li Y; Chen X; Shang L; Tai YT; Feng X; Acharya P; Acharya C; Xu Y; Deng S; Hao M; Zou D; Zhao Y; Ru K; Qiu L; An G
    Oncotarget; 2017 Mar; 8(12):18792-18801. PubMed ID: 27852046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio are Associated with the Prognosis of Group 3 and Group 4 Medulloblastoma.
    Li K; Duan WC; Zhao HB; Wang L; Wang WW; Zhan YB; Sun T; Zhang FJ; Yu B; Bai YH; Wang YM; Ji YC; Zhou JQ; Liu XZ; Zhang ZF; Zhang ZY
    Sci Rep; 2019 Sep; 9(1):13239. PubMed ID: 31519974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biologically driven cut-off definition of lymphocyte ratios in metastatic breast cancer and association with exosomal subpopulations and prognosis.
    Gerratana L; Basile D; Toffoletto B; Bulfoni M; Zago S; Magini A; Lera M; Pelizzari G; Parisse P; Casalis L; Vitale MG; Fanotto V; Bonotto M; Caponnetto F; Bartoletti M; Lisanti C; Minisini AM; Emiliani C; Di Loreto C; Fasola G; Curcio F; Beltrami AP; Cesselli D; Puglisi F
    Sci Rep; 2020 Apr; 10(1):7010. PubMed ID: 32332763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prognostic value of combining preoperative serum tumor markers and peripheral blood routine indexes in patients with colorectal cancer].
    Huang L; Fang J; Wu J; Zhou X; Wei H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Dec; 21(12):1421-1426. PubMed ID: 30588596
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophil/lymphocyte ratio, monocyte/lymphocyte ratio, and mean platelet volume as systemic inflammatory markers in different states of bipolar disorder.
    Inanli I; Aydin M; Çaliskan AM; Eren I
    Nord J Psychiatry; 2019 Aug; 73(6):372-379. PubMed ID: 31304832
    [No Abstract]   [Full Text] [Related]  

  • 35. Are Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios Prognostic Indicators in Patients With Chronic Obstructive Pulmonary Disease in Intensive Care Units?
    Eraslan Doganay G; Cirik MO
    Cureus; 2022 Mar; 14(3):e23499. PubMed ID: 35494932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of systemic inflammatory response markers as independent prognostic factors for advanced pancreatic cancer.
    Qi Q; Geng Y; Sun M; Wang P; Chen Z
    Pancreatology; 2015; 15(2):145-50. PubMed ID: 25641673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Can the neutrophil-lymphocyte ratio and platelet-lymphocyte ratio be beneficial in predicting lymph node metastasis and promising prognostic markers of gastric cancer patients? Tumor maker retrospective study.
    Zhang LX; Wei ZJ; Xu AM; Zang JH
    Int J Surg; 2018 Aug; 56():320-327. PubMed ID: 29969732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and prognostic value of ratios of platelet lymphocyte, neutrophil lymphocyte and lymphocyte monocyte in breast cancer patients.
    Song D; Li X; Zhang X
    Am J Transl Res; 2022; 14(5):3233-3239. PubMed ID: 35702097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of neutrophil/lymphocyte ratio and platelet/lymphocyte ratio with ER and PR in breast cancer patients and their changes after neoadjuvant chemotherapy.
    Xu J; Ni C; Ma C; Zhang L; Jing X; Li C; Liu Y; Qu X
    Clin Transl Oncol; 2017 Aug; 19(8):989-996. PubMed ID: 28247194
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative monocyte-to-lymphocyte ratio predicts recurrence in gastrointestinal stromal tumors.
    Cananzi FCM; Minerva EM; Samà L; Ruspi L; Sicoli F; Conti L; Fumagalli Romario U; Quagliuolo VL
    J Surg Oncol; 2019 Jan; 119(1):12-20. PubMed ID: 30426498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.